DR.WU Business Summary

DR.WU Skincare Co., Ltd. (6523.TWO) is a premier Taiwanese cosmeceutical firm that generates revenue through the research, development, and omnichannel distribution of high-performance clinical skincare products. The company’s business model is centered on the sale of proprietary formulations across three primary segments: high-potency serums (notably its Mandelik and Hyalucomplex lines), medical-grade facial masks, and specialized post-procedure recovery treatments. DR.WU leverages a robust distribution network comprising leading regional drugstores such as Watsons and Cosmed, department store counters, and a high-growth global e-commerce infrastructure. In the competitive landscape, DR.WU maintains a dominant "doctor-brand" position in the Greater China and Southeast Asian markets, competing directly with domestic rival Neogence, Japanese clinical leader Dr.Ci:Labo, and L’Oréal’s SkinCeuticals. The company distinguishes itself by bridging the gap between professional dermatological procedures and at-home maintenance, maintaining a premium price point supported by rigorous clinical validation. The company was co-founded in 2003 by Dr. Ying-Chin Wu, a renowned dermatologist frequently cited as the "Father of Aesthetic Medicine" in Taiwan, and his son, Eric Wu (Yi-Jui Wu). Dr. Ying-Chin Wu continues to provide the clinical R&D foundation as a key Director, while Eric Wu serves as the current Chairman and CEO, bringing a strategic pedigree that includes an MBA from Columbia University and a background in scaling international retail operations. The leadership team was instrumental in institutionalizing the brand, notably securing a landmark Series B investment from L Catterton (the private equity arm of LVMH) in 2014, which accelerated its IPO on the Taipei Exchange (TPEx) and global expansion. The board is characterized by a mix of clinical expertise and seasoned retail management, ensuring the brand remains at the forefront of the functional skincare and "clean beauty" trends as of early 2026.